Conditions: Alzheimer's Disease
Keywords: Alzheimer's Disease Rosiglitazone
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 33
Healthy volunteers: no

Brief summary:
This is an open-label extension to study 49653/461, to assess the long-term safety of rosiglitazone (extended release tablets) in subjects with mild to moderate Alzheimer's Disease.

Detailed description:

Arms:
arm 1: Extended Release Tablets

Interventions: intervention 1: rosiglitazone
Intervention descriptions: intervention 1: Extended Release Tablets

Protocol document: